ES8300089A1 - Procedimiento para preparar nuevos derivados de acidos 16-hidroxiprostanoicos 4,5-insaturados. - Google Patents
Procedimiento para preparar nuevos derivados de acidos 16-hidroxiprostanoicos 4,5-insaturados.Info
- Publication number
- ES8300089A1 ES8300089A1 ES507577A ES507577A ES8300089A1 ES 8300089 A1 ES8300089 A1 ES 8300089A1 ES 507577 A ES507577 A ES 507577A ES 507577 A ES507577 A ES 507577A ES 8300089 A1 ES8300089 A1 ES 8300089A1
- Authority
- ES
- Spain
- Prior art keywords
- unsaturated
- acid derivatives
- prostanoic acid
- prostanoic
- pharmacological properties
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 title 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/80—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
- C07C59/82—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
Abstract
UN METODO DE FILTRAR UNA SEÑAL DE TENSION DE ENTRADA CON UN CIRCUITO FILTRANTE. CONSTA DE LAS SIGUIENTES ETAPAS: 1<002> COMPARAR LA SEÑAL DE ENTRADA CON OTRA ANALOGICA DE SALIDA DE REALIMENTACION EN UN CIRCUITO SUMADOR PARA OBTENER UNA SEÑAL DE ERROR REPRESENTATIVA DE LA DIFERENCIA DE DICHAS SEÑALES DE RETROACCION. 2<002> GENERAR POR MEDIO DE UN OSCILADOR CONTROLADO EN TENSION UNA SEÑAL DE FRECUENCIA PROPORCIONAL A LA SEÑAL DE ERROR. 3<002> INTEGRAR LA SEÑAL DE FRECUENCIA DIVIDIDA EN UN CIRCUITO ACUMULADOR. 4<002> CONVERTIR LA SEÑAL NUMERICA INTEGRADA DEL CIRCUITO ACUMULADOR EN UN CONVERTIDOR DE NUMERICO EN ANALOGICO PARA OBTENER UNA SEÑAL ANALOGICA DE SALIDA. 5<002> DEVOLVER O LLEVAR A REALIMENTACION DICHA SEÑAL ANALOGICA DE SALIDA POR UNA CONEXION DE REALIMENTACION PARA DAR LA SEÑAL DE CIRCUITO COMPARADOR. LA GENERACION DE UNA SEÑAL DE FRECUENCIA INCLUYE LA ACCION DE GENERAR UNA SEÑAL DE CONTROL PARA UNOS CONTADORES DE DOBLE SENTIDO ASOCIADO AL OSCILADOR CONTROLADO EN TENSION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/098,290 US4271314A (en) | 1979-11-28 | 1979-11-28 | 4,5-Unsaturated prostanoic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8300089A1 true ES8300089A1 (es) | 1982-10-01 |
| ES507577A0 ES507577A0 (es) | 1982-10-01 |
Family
ID=22268646
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES497260A Expired ES8204418A1 (es) | 1979-11-28 | 1980-11-28 | Procedimiento para preparar nuevos derivados de acidos 16-hidroxiprostanoicos 4,5-insaturados |
| ES507577A Granted ES507577A0 (es) | 1979-11-28 | 1981-11-30 | Procedimiento para preparar nuevos derivados de acidos 16-hidroxiprostanoicos 4,5-insaturados. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES497260A Expired ES8204418A1 (es) | 1979-11-28 | 1980-11-28 | Procedimiento para preparar nuevos derivados de acidos 16-hidroxiprostanoicos 4,5-insaturados |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4271314A (es) |
| JP (1) | JPS5699457A (es) |
| AT (1) | AT379144B (es) |
| AU (1) | AU539192B2 (es) |
| BE (1) | BE886370A (es) |
| CA (1) | CA1192903A (es) |
| CH (1) | CH646147A5 (es) |
| DE (1) | DE3044794A1 (es) |
| DK (2) | DK504680A (es) |
| ES (2) | ES8204418A1 (es) |
| FI (1) | FI71552C (es) |
| FR (1) | FR2473516A1 (es) |
| GB (1) | GB2065117B (es) |
| GR (1) | GR72283B (es) |
| IE (1) | IE50574B1 (es) |
| IL (1) | IL61575A (es) |
| IT (1) | IT1207155B (es) |
| NL (1) | NL191386C (es) |
| NO (1) | NO155289C (es) |
| NZ (1) | NZ195666A (es) |
| PT (1) | PT72129B (es) |
| SE (1) | SE436873B (es) |
| ZA (1) | ZA807415B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4529811A (en) * | 1981-03-02 | 1985-07-16 | G. D. Searle & Co. | Process for isolating organic compounds and lithium salt complexes useful in said process |
| US4312994A (en) * | 1981-03-25 | 1982-01-26 | G. D. Searle & Co. | α Chain dienic prostanoic acid derivatives |
| US4499296A (en) * | 1983-11-14 | 1985-02-12 | G. D. Searle & Co. | Omega cycloalkyl prostaglandins |
| US4754059A (en) * | 1984-11-07 | 1988-06-28 | G. D. Searle & Co. | Omega cycloalkyl prostaglandins |
| GB8410396D0 (en) * | 1984-04-24 | 1984-05-31 | Glaxo Group Ltd | Carbocyclic compounds |
| US5011958A (en) * | 1987-06-08 | 1991-04-30 | G. D. Searle & Co. | Process for preparing higher order cuprate complexes |
| US4785124A (en) * | 1987-06-08 | 1988-11-15 | G. D. Searle & Co. | Process for preparing higher order cuprate complexes |
| US4777275A (en) * | 1987-06-09 | 1988-10-11 | G. D. Searle & Co. | Process of preparing higher order cuprate complexes |
| US5191109A (en) * | 1990-02-02 | 1993-03-02 | Sumitomo Chemical Company, Limited | Process for preparing optically active cyclopentenones |
| WO1999002147A1 (en) | 1997-07-09 | 1999-01-21 | Androsolutions, Inc. | Improved methods and compositions for treating male erectile dysfunction |
| US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
| EP1245562A4 (en) | 2000-01-05 | 2004-12-15 | Ono Pharmaceutical Co | ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3965143A (en) * | 1974-03-26 | 1976-06-22 | G. D. Searle & Co. | 16-Oxygenated prostanoic acid derivatives |
| US4028419A (en) * | 1976-01-08 | 1977-06-07 | The Upjoin Company | 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds |
| GB1595119A (en) * | 1977-05-31 | 1981-08-05 | Sumitomo Chemical Co | 2-hydroxycyclopentaneacetic acid y-lactones and processes for producing them |
-
1979
- 1979-11-28 US US06/098,290 patent/US4271314A/en not_active Expired - Lifetime
-
1980
- 1980-11-27 NL NL8006473A patent/NL191386C/xx not_active IP Right Cessation
- 1980-11-27 IE IE2471/80A patent/IE50574B1/en not_active IP Right Cessation
- 1980-11-27 NO NO803592A patent/NO155289C/no unknown
- 1980-11-27 CH CH879980A patent/CH646147A5/de not_active IP Right Cessation
- 1980-11-27 IT IT8050259A patent/IT1207155B/it active
- 1980-11-27 BE BE0/202950A patent/BE886370A/fr not_active IP Right Cessation
- 1980-11-27 AT AT0579280A patent/AT379144B/de not_active IP Right Cessation
- 1980-11-27 FI FI803685A patent/FI71552C/fi not_active IP Right Cessation
- 1980-11-27 SE SE8008300A patent/SE436873B/sv not_active IP Right Cessation
- 1980-11-27 IL IL61575A patent/IL61575A/xx unknown
- 1980-11-27 DK DK504680A patent/DK504680A/da not_active Application Discontinuation
- 1980-11-27 CA CA000365636A patent/CA1192903A/en not_active Expired
- 1980-11-27 AU AU64766/80A patent/AU539192B2/en not_active Ceased
- 1980-11-27 ZA ZA00807415A patent/ZA807415B/xx unknown
- 1980-11-27 NZ NZ195666A patent/NZ195666A/xx unknown
- 1980-11-28 PT PT72129A patent/PT72129B/pt unknown
- 1980-11-28 DE DE19803044794 patent/DE3044794A1/de active Granted
- 1980-11-28 GB GB8038362A patent/GB2065117B/en not_active Expired
- 1980-11-28 FR FR8025347A patent/FR2473516A1/fr active Granted
- 1980-11-28 GR GR63485A patent/GR72283B/el unknown
- 1980-11-28 ES ES497260A patent/ES8204418A1/es not_active Expired
- 1980-11-28 JP JP16791280A patent/JPS5699457A/ja active Granted
-
1981
- 1981-11-30 ES ES507577A patent/ES507577A0/es active Granted
-
1987
- 1987-11-23 DK DK613487A patent/DK162281C/da active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8204418A1 (es) | Procedimiento para preparar nuevos derivados de acidos 16-hidroxiprostanoicos 4,5-insaturados | |
| AU504482B2 (en) | ELECTROLYTIC DIAPHRAGM v, F'r L | |
| ES8301870A1 (es) | Procedimiento para preparar derivados de acidos 16-hidroxi- prostanoicos 4,5-insaturados | |
| IE820686L (en) | Prostanoic acid derivatives. | |
| AU500164B2 (en) | 3, 4, 5-substituted benzenesulfonformamidines | |
| AU505725B2 (en) | 2, 9-dioxatricyclo ( 4,3,1,03,70 dercanes | |
| IE45877L (en) | Delta-1,4-pregnadienes | |
| ES479205A1 (es) | Un procedimiento para la preparacion de o-carbamoiloximas de 2,3-dihidro-4h-1-benzopiran-4-ona. | |
| AU512931B2 (en) | 13, 14-didehydro prostaglandin | |
| AU526670B2 (en) | Production of 5.6 dihydro-2-methyl-n-phenyl-1,4-oxathiin-3- carboxamide | |
| FR2407916B1 (es) | ||
| IE781069L (en) | 3-(4-chromanylamino)-2-oxazolidinones | |
| AU496088B2 (en) | Prostaglandin-type 1, 9-lactones | |
| AU475825B2 (en) | 1, 2-disubstituted hydrazines | |
| AU1428976A (en) | Prostaglandin-type 1, 9-lactones | |
| AU483806B2 (en) | 2,4,5,6 - tetrahydrocyclopenta (c) pyrrole -4- (thio) - carboxamides | |
| AU496086B2 (en) | Prostaglandin type 1, 15-lactones | |
| AU6704974A (en) | 2,4,5,6 - tetrahydrocyclopenta (c) pyrrole -4- (thio) - carboxamides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970303 |